- Filed
- Apr 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 1, 2026 | 394.2M sh |
| Shares Diluted | Q1 2026 · Mar 2, 2025 | 400.05M sh |
| Stock Repurchased | Q1 2026 · Mar 1, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 2, 2025 | $30M |
| Dividends Paid | Q1 2026 · Mar 1, 2026 | $53.8M |
| Dividends Paid | Q1 2026 · Mar 2, 2025 | $51.4M |
| Capex | Q1 2026 · Mar 1, 2026 | $59.4M |
| Capex | Q1 2026 · Mar 2, 2025 | $66.6M |
| Operating Cash Flow | Q1 2026 · Mar 1, 2026 | $211.5M |
| Operating Cash Flow | Q1 2026 · Mar 2, 2025 | $52.5M |
| Long Term Debt | Q1 2026 · Mar 1, 2026 | $1.05B |
| Long Term Debt | Q1 2026 · Nov 30, 2025 | $1.04B |
| Short Term Investments | Q1 2026 · Mar 1, 2026 | $95.4M |
| Short Term Investments | Q1 2026 · Nov 30, 2025 | $90.9M |
| Cash And Equivalents | Q1 2026 · Mar 1, 2026 | $716.6M |
| Cash And Equivalents | Q1 2026 · Nov 30, 2025 | $757.9M |
| Current Liabilities | Q1 2026 · Mar 1, 2026 | $1.85B |
| Current Liabilities | Q1 2026 · Nov 30, 2025 | $2.03B |
| Total Liabilities | Q1 2026 · Mar 1, 2026 | $4.37B |
| Total Liabilities | Q1 2026 · Nov 30, 2025 | $4.57B |
| Current Assets | Q1 2026 · Mar 1, 2026 | $2.91B |
| Current Assets | Q1 2026 · Nov 30, 2025 | $3.15B |
| Total Assets | Q1 2026 · Mar 1, 2026 | $6.57B |
| Total Assets | Q1 2026 · Nov 30, 2025 | $6.85B |
| Total Assets restated | Q1 2026 · Mar 2, 2025 | $6.85B |
| Eps Diluted | Q1 2026 · Mar 1, 2026 | $0.45 |
| Eps Diluted | Q1 2026 · Mar 2, 2025 | $0.34 |
| Eps Basic | Q1 2026 · Mar 1, 2026 | $0.45 |
| Eps Basic | Q1 2026 · Mar 2, 2025 | $0.34 |
| Sga Expense | Q1 2026 · Mar 1, 2026 | $871.7M |
| Sga Expense | Q1 2026 · Mar 2, 2025 | $749.3M |
| Operating Income | Q1 2026 · Mar 1, 2026 | $198.7M |
| Operating Income | Q1 2026 · Mar 2, 2025 | $191.6M |
| Gross Profit | Q1 2026 · Mar 1, 2026 | $1.08B |
| Gross Profit | Q1 2026 · Mar 2, 2025 | $947.6M |
| Cost Of Revenue | Q1 2026 · Mar 1, 2026 | $664.2M |
| Cost Of Revenue | Q1 2026 · Mar 2, 2025 | $579.2M |
| Revenue | Q1 2026 · Mar 1, 2026 | $1.74B |
| Revenue | Q1 2026 · Mar 2, 2025 | $1.53B |